Exact Mass: 298.1812
Exact Mass Matches: 298.1812
Found 111 metabolites which its exact mass value is equals to given mass value 298.1812,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Artemether
Artemether is an artemisinin derivative that is artemisinin in which the lactone has been converted to the corresponding lactol methyl ether. It is used in combination with lumefantrine as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. It has a role as an antimalarial. It is a sesquiterpenoid, a cyclic acetal, an organic peroxide, an artemisinin derivative and a semisynthetic derivative. Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. An artemisinin derivative that is used in the treatment of MALARIA. Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.
Minaprine
Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants
Diphthamide
Diphthamide is a modified histidine amino acid found in eukaryotic elongation factor 2 (eEF-2). It is usually found at position H715 in mammalian eEF2 (H699 in yeast). This residue is modified by the protein encoded by the OVCA1 gene (homolog of DPH1 in mice). DPH1 knockout mice are inviable while heterozygotes develop diverse types of carcinomas and sarcomas. In humans, OVCA1 is frequently found mutated in ovarian cancer. (Wikipedia)
9'-desmethylgranisetron
9-desmethylgranisetron is a metabolite of granisetron. Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. (Wikipedia)
3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-cyclohexanone
alpha-Artemether
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.
Aigialone
A furopyran that is 5,6-dihydro-4H-furo[2,3-b]pyran-3(2H)-one which is substituted by hydroxy groups at positions 4 and 5, methyl groups at positions 2 and 5, and a heptyl group at position 6 (the 2R,4R,5S,6R stereoisomer). Isolated from the mangrove fungus Aigialus parvus BCC 5311 and from Phaeoacremonium sp., an endophytic fungus from Senna spectabilis.
(2E)-4-Hydroxy-4-{4-hydroxy-2-[(1E)-6-hydroxy-1-hepten-1-yl]cyclopentyl}-2-butenoic acid
2-[(1S,8abeta)-1beta,5alpha,7alpha-Trihydroxy-4aalpha,8alpha-dimethyldecalin-2alpha-yl]acrylic acid methyl ester
1-(2,4a,8-trihydroxy-1,2,6-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-3-hydroxy-1-propanone
4alpha,8alpha-dihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6alpha,12olide
methyl 1beta,6alpha,15-trihydroxy-4beta,15-dihydrocostate
Artemether
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.
C16H26O5_Pentanoic acid, 3-methyl-, 5-hydroxy-3-(hydroxymethyl)-6-(1-methylethyl)-2-oxo-3-cyclohexen-1-yl ester
[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate
(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one
(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one_major
N-(9-azabicyclo[3.3.1]nonan-3-yl)-1-methylindazole-3-carboxamide
13,14-dihydro-15-keto-tetranor Prostaglandin D2
1-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]piperidine-3-carboxylic acid
3-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid
4-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid
tert-Butyl 3-(morpholine-4-carbonyl)piperidine-1-carboxylate
butyl prop-2-enoate,ethene,oxiran-2-ylmethyl 2-methylprop-2-enoate
5-methyl-2-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrimidine-2,4-diamine
2-[(4-TERT-BUTYL-2-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID
Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat
3,5-Dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-pyrazole
N-[2-[di(propan-2-yl)amino]ethyl]-4-methylbenzenesulfonamide
(3AR,7AS)-2-TERT-BUTYL7A-ETHYLHEXAHYDRO-1H-PYRROLO[3,4-C]PYRIDINE-2,7A(3H)-DICARBOXYLATE
1,2-Ethanediamine,N1-[[[2-(trimethoxysilyl)ethyl]phenyl]methyl]-
albumin, horse
(1R,4R)-N,N-Bis-(4-Methyl-pyriMidin-2-yl)-cyclohexane-1,4-diaMine
2-(2,5-dimethyl-1H-pyrrol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
1-Methyl-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-1H-indazole-3-carboxamide
2-(3-Carboxyamido-3-(trimethylammonio)propyl)histidine
3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-cyclohexanone
4,8-Dihydroxy-2-(1-hydroxyheptyl)-2,3,4,6,7,8-hexahydrochromen-5-one
2-[4-amino-4-oxo-3-(trimethylammonio)butyl]-L-histidine
[(2S,3S,4R,5R)-5-[6-(dimethylamino)-6,7-dihydro-3H-purin-9-ium-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]azanium
[1-amino-4-[5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl]-1-oxobutan-2-yl]-trimethylazanium
2,3,4,5-tetranor-15-oxoprostaglandin F2alpha
A prostanoid that is prostaglandin F2alpha which is lacking two methylenes in the carboxyalkyl chain and in which the hydroxy group at position 15 has been oxidised to the corresponding ketone.
(2E,4R)-4-hydroxy-4-{(1R,2S,4S)-4-hydroxy-2-[(1E,6S)-6-hydroxyhept-1-en-1-yl]cyclopentyl}but-2-enoic acid
(2S)-3-{2-[(3S)-4-amino-4-oxo-3-(trimethylazaniumyl)butyl]-1H-imidazol-4-yl}-2-azaniumylpropanoate
(E)-4-hydroxy-4-[4-hydroxy-2-[(E)-6-hydroxyhept-1-enyl]cyclopentyl]but-2-enoic acid
(2R,3S,4R,7S)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-4,7-dihydro-2H-furo[3,4-b]pyran-5-one
2alpha-[(S)-1-Hydroxyheptyl]-4beta,8alpha-dihydroxy-3,4,7,8-tetrahydro-2H-1-benzopyran-5(6H)-one
5,6,7,14,15,16-Hexahydro-6,15-methanobenzo(A)naphtho(2,3-F)cyclodecene
(2S,3S)-4-Benzyloxy-2-methoxyethoxymethoxy-3-methylbutanol
3,3,4-Trimethoxy-8,8,9,9-tetramethylbicyclo(5.2.0)nonane-2,6-dione
2,2,3-Trimethoxy-6-(1,1,2-trimethyl-2-propenyl)cycloheptane-1,5-dione
isoaigialone B
A gamma-lactone that is 3,4,5,7-tetrahydro-2H-furo[3,4-b]pyran substituted by heptyl, methyl, hydroxy, hydroxy, oxo and methyl groups at positions 2R, 3S, 3S, 4R, 5 and 7R, respectively. It is isolated from the endophytic fungus Phaeoacremonium sp. and exhibits antifungal activities.
methyl (5s,8r)-5-hydroxy-5-(hydroxymethyl)-8-[(2s)-1-hydroxypropan-2-yl]-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylate
methyl 2-[(1s,2s,4ar,5r,7s,8r,8as)-1,5,7-trihydroxy-4a,8-dimethyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate
bisaborosaol c1
{"Ingredient_id": "HBIN018587","Ingredient_name": "bisaborosaol c1","Alias": "NA","Ingredient_formula": "C16H26O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14481","TCMID_id": "2420","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bisaborosaol c2
{"Ingredient_id": "HBIN018588","Ingredient_name": "bisaborosaol c2","Alias": "NA","Ingredient_formula": "C16H26O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14482","TCMID_id": "2421","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
